Evidence map›Paper›PMID 38029754›Full record

ArticleMed (New York, N.Y.)2023

Cardiac radiation improves ventricular function in mice and humans with cardiomyopathy.

Lauren N Pedersen, Carla Valenzuela Ripoll, Mualla Ozcan, Zhen Guo, Aynaz Lotfinaghsh, Shiyang Zhang, Sherwin Ng, Carla Weinheimer, Jessica Nigro, Attila Kovacs and 25 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Med (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06299176 (Phase 1 Feasibility and Safety of Whole Heart Radiotherapy for End-stage Heart Failure), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06299176 phase1enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Phase 1 Feasibility and Safety of Whole Heart Radiotherapy for End-stage Heart Failure: First In-human Treatments

TypeinterventionalSponsorMcGill University Health Centre/Research Institute of the McGill University Health CentreRan2025 to 2026Enrolled6ConditionsHeart Failure NYHA Class III, Heart Failure NYHA Class IV, End-stage Heart Failure, Heart Failure With Reduced Ejection FractionArmsWhole Heart Radiation Therapy
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Development of a prospective clinical workflow for proton beam therapy of ventricular tachycardia.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. METTL3 Modulates Radiation-Induced Cardiac Fibrosis via the Akt/mTOR Pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Radiation therapy for ventricular arrhythmias.Journal of medical imaging and radiation oncology · 2024
    Review
  20. Case of Successful Sympathetic Nerve Modulation by Targeted Heavy Ion Radiotherapy for Idiopathic Ventricular Tachycardia.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 1 institution in 1 country.

Lauren N PedersenWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Carla Valenzuela RipollWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Mualla OzcanWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Zhen GuoWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Aynaz LotfinaghshWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Shiyang ZhangWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Sherwin NgWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Carla WeinheimerWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Jessica NigroWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Attila KovacsWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Ahmed DiabWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Amanda KlaasWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Felicia GroganWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Yoonje ChoWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Anahita AtaranWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Hannah LuehmannWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Abigail HeckWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Kollin KolbWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Lori StrongWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Rachita NavaraWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Gerard M WallsPatrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT97AE, Northern Ireland.
Geoff HugoWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Pamela SamsonWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Daniel CooperWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Francisco J ReynosoWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Julie K SchwarzWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Kaitlin MooreWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Kory LavineWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Stacey L RentschlerWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Yongjian LiuWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Pamela K WoodardWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Clifford RobinsonWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Phillip S CuculichWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Carmen BergomWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA. Electronic address: cbergom@wustl.edu.
Ali JavaheriWashington University School of Medicine in St. Louis, St. Louis, MO 63110, USA; John J. Cochran Veterans Affairs Medical Center, St. Louis, MO 63106, USA. Electronic address: ali.javaheri@wustl.edu.
Washington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Jeffrey Wade Brown · 2000 to 2026
$30.8M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
Training/DisseminationP41EB025815 · NIBIB · WASHINGTON UNIVERSITY · PI Robert J. Gropler · 2018 to 2026
$12.7M
PRINCIPLES IN CARDIVASCULAR RESEARCH TRAINING PROGRAMT32HL007081 · NHLBI · WASHINGTON UNIVERSITY · PI Abhinav Diwan, Karen Ellen Joynt Maddox · 1985 to 2026
$10.6M
MOLECULAR ONCOLOGY TRAINING GRANTT32CA113275 · NCI · WASHINGTON UNIVERSITY · PI Matthew J Walter · 2006 to 2026
$5.7M
Targeted Molecular Probes for Atherosclerosis Imaging and TherapyR35HL145212 · NHLBI · WASHINGTON UNIVERSITY · PI LIU, YONGJIAN · 2019 to 2025
$5.1M
Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart FailureR35HL161185 · NHLBI · WASHINGTON UNIVERSITY · PI Kory J. Lavine · 2022 to 2026
$4.3M
Mechanistic Basis of Cardiac Irradiation as a Therapy for Ventricular TachycardiaR01HL163274 · NHLBI · WASHINGTON UNIVERSITY · PI RENTSCHLER, STACEY LYNN, SCHWARZ, JULIE KRISTINA · 2022 to 2025
$3.1M
Apolipoprotein M: a novel regulator of myocardial AutophagyR01HL155344 · NHLBI · WASHINGTON UNIVERSITY · PI JAVAHERI, ALI · 2021 to 2025
$3.1M
NCI NIH HHS P30 CA091842NCI NIH HHS T32 CA113275NHLBI NIH HHS K08 HL138262NHLBI NIH HHS R01 HL147884NHLBI NIH HHS R01 HL155344NHLBI NIH HHS R01 HL163274NHLBI NIH HHS R35 HL145212NHLBI NIH HHS R35 HL161185NHLBI NIH HHS T32 HL007081NIAID NIH HHS T32 AI007163NIBIB NIH HHS P41 EB025815NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK052574NIDDK NIH HHS P30 DK056341NIH HHS S10 OD020136NIH HHS S10 OD028597NIH HHS S10 OD030403
6 · The paper itself

Abstract

backgroundRapidly dividing cells are more sensitive to radiation therapy (RT) than quiescent cells. In the failing myocardium, macrophages and fibroblasts mediate collateral tissue injury, leading to progressive myocardial remodeling, fibrosis, and pump failure. Because these cells divide more rapidly than cardiomyocytes, we hypothesized that macrophages and fibroblasts would be more susceptible to lower doses of radiation and that cardiac radiation could therefore attenuate myocardial remodeling.

methodsIn three independent murine heart failure models, including models of metabolic stress, ischemia, and pressure overload, mice underwent 5 Gy cardiac radiation or sham treatment followed by echocardiography. Immunofluorescence, flow cytometry, and non-invasive PET imaging were employed to evaluate cardiac macrophages and fibroblasts. Serial cardiac magnetic resonance imaging (cMRI) from patients with cardiomyopathy treated with 25 Gy cardiac RT for ventricular tachycardia (VT) was evaluated to determine changes in cardiac function.

findingsIn murine heart failure models, cardiac radiation significantly increased LV ejection fraction and reduced end-diastolic volume vs. sham. Radiation resulted in reduced mRNA abundance of B-type natriuretic peptide and fibrotic genes, and histological assessment of the LV showed reduced fibrosis. PET and flow cytometry demonstrated reductions in pro-inflammatory macrophages, and immunofluorescence demonstrated reduced proliferation of macrophages and fibroblasts with RT. In patients who were treated with RT for VT, cMRI demonstrated decreases in LV end-diastolic volume and improvements in LV ejection fraction early after treatment.

conclusionsThese results suggest that 5 Gy cardiac radiation attenuates cardiac remodeling in mice and humans with heart failure.

fundingNIH, ASTRO, AHA, Longer Life Foundation.

Indexed as

CardiomyopathiesHeart FailureAnimalsFibrosisHumansMiceMyocytes, CardiacVentricular FunctionVentricular Remodelingcardiomyopathyfibrosisheart failureinflammationmacrophagesPre-clinical researchproliferationradiationremodelingX-ray

Identifiers

PMID38029754
PMCPMC10994563
OpenAlexW4389101112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.